Alpha 2.0
Login Register
» Articles » PMID: 25688540

A Simple Flow Cytometry-based Barcode for Routine Authentication of Multiple Myeloma and Mantle Cell Lymphoma Cell Lines

Overview
Journal Cytometry A
Specialties Cell Biology
Radiology
Date 2015 Feb 18
PMID 25688540
Citations 9
Authors
Sophie Maiga
Carole Brosseau
Geraldine Descamps
Christelle Dousset
Patricia Gomez-Bougie
David Chiron
Emmanuelle Menoret
Charlotte Kervoelen
Henri Vie
Anne Cesbron
Agnes Moreau-Aubry
Martine Amiot
Catherine Pellat-Deceunynck
Affiliations
Soon will be listed here.
Citing Articles

Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells.

Durand R, Bellanger C, Descamps G, Dousset C, Maiga S, Derrien J Hemasphere. 2024; 8(10):e70016.

PMID: 39380841 PMC: 11460984. DOI: 10.1002/hem3.70016.

Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.

Durand R, Bellanger C, Kervoelen C, Tessoulin B, Dousset C, Menoret E Haematologica. 2024; 109(8):2574-2584.

PMID: 38385294 PMC: 11290505. DOI: 10.3324/haematol.2023.284345.

BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival.

Champion O, Soler A, Maiga S, Bellanger C, Pellat-Deceunynck C, Talbot A Front Oncol. 2023; 13:1196005.

PMID: 37534243 PMC: 10393035. DOI: 10.3389/fonc.2023.1196005.

The Impact of Panobinostat on Cell Death in Combination with S63845 in Multiple Myeloma Cells.

Tagoug A, Safra I Indian J Hematol Blood Transfus. 2023; 39(2):245-257.

PMID: 37006981 PMC: 10064410. DOI: 10.1007/s12288-022-01584-4.

Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact.

Devin J, Kassambara A, Bruyer A, Moreaux J, Bret C J Clin Med. 2019; 8(7).

PMID: 31336593 PMC: 6678649. DOI: 10.3390/jcm8071074.